Literature DB >> 7621317

Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories.

W B Kannel1.   

Abstract

BACKGROUND: The major cardiovascular risk factors adversely affect all vascular territories, increasing the vulnerability to multiple clinical manifestations of atherosclerosis. PATIENTS: The population at risk was the Farmingham cohort of 5209 men and women assessed bienially for the development of overt events of coronary heart disease (CHD), congestive heart failure, intermittent claudication, and atheroembolic brain infarction.
RESULTS: In persons younger than 65 years, all the major risk factors were found to impact significantly on the incidence of coronary heart disease and intermittent claudication. For stroke and cardiac failure, all but the serum cholesterol level were important. In those older than 65 years, serum total cholesterol levels and smoking no longer influenced the incidence of coronary heart disease. The ratio of total- to high-density-lipoprotein-cholesterol levels, however, was related to all cardiovascular outcomes except stroke at all ages. The impact of cigarette smoking on stroke and intermittent claudication persisted in advanced age.
CONCLUSION: Modification of risk factors for the purpose of preventing a particular cardiovascular event should also prevent other outcomes. The impact of any particular risk factor on any atherosclerotic cardiovascular disease outcome is profoundly influenced by the frequent coexistence of other risk factors. A correct appraisal of the hazard and urgency for treatment is best obtained from a cardiovascular risk profile estimating the conditional probability of an event given the existing constellation of factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7621317

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  26 in total

Review 1.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 2.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.

Authors:  William B Kannel; Philip A Wolf
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

3.  In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis.

Authors:  Ji Zhang; Kelley A Burridge; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

4.  [S3 guidelines for diagnostics and treatment of peripheral arterial occlusive disease].

Authors:  P Huppert; J Tacke; H Lawall
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

5.  Impact of adherence to statins on coronary artery disease in primary prevention.

Authors:  Marie-Hélène Bouchard; Alice Dragomir; Lucie Blais; Anick Bérard; Danielle Pilon; Sylvie Perreault
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

6.  7(th) Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2016-05-25

7.  Adherence to nicotine replacement patch therapy in cardiovascular patients.

Authors:  Louise C W Wiggers; Ellen M A Smets; Frans J Oort; Marja N Storm-Versloot; Hester Vermeulen; Lucas B M van Loenen; Ron J G Peters; Hanneke C J M de Haes; Dink A Legemate
Journal:  Int J Behav Med       Date:  2006

8.  Risk of a coronary event in patients after ischemic stroke or transient ischemic attack.

Authors:  Ivan Poledník; Jakub Sulzenko; Petr Widimsky
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

9.  Mortality following operations for lower extremity peripheral arterial disease.

Authors:  Tracie C Collins; David Nelson; Jasjit S Ahluwalia
Journal:  Vasc Health Risk Manag       Date:  2010-05-06

Review 10.  Aspirin for the prevention of cardiovascular events in the elderly.

Authors:  Isabelle Mahé; Alain Leizorovicz; Charles Caulin; Jean-François Bergmann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.